{Reference Type}: Journal Article
{Title}: Type 1 diabetes and pregnancy: An update on glucose monitoring and insulin treatment.
{Author}: Amigó J;Corcoy R;Amigó J;Corcoy R;
{Journal}: Endocrinol Diabetes Nutr (Engl Ed)
{Volume}: 69
{Issue}: 6
{Year}: Jun-Jul 2022
{Factor}: 1.833
{DOI}: 10.1016/j.endien.2022.06.008
{Abstract}: The relevance of type 1 diabetes during pregnancy stems from its impact on the health of mother and offspring and its increasing prevalence. Glycemic control during pregnancy is one of the main risk factors for adverse events. Besides, treatment becomes a major challenge not only due to the modifications in insulin requirements due to changes in hormones and cytokines but also to the stricter control targets. Given the recent appearance of new ultra-rapid and basal insulin analogues and the constant evolution of technology to treat people with diabetes, we review these aspects in relation to the treatment of women with type 1 diabetes during pregnancy.